“The experiment demonstrated that the drug acts during the early phase of chikungunya replication after virus entry,” says Sanketkumar Nehul from IIT Roorkee and the first author of the paper.

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

The research suggests that Efavirenz, a drug commonly used to treat HIV, may help reduce the replication of the Chikungunya virus. With promising results observed in both laboratory settings and ...

Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...

as it has been shown to reduce Chikungunya virus replication both in vitro and in mice models. (Handout) As per IIT Roorkee, Efavirenz, a drug widely used for HIV treatment, may serve as an ...